People are taking a 20-cent ‘wonder drug’ to slow aging and lose weight. Some doctors say it’s promising.
Metformin, is it time?
Related Articles
Screening for Speech and Language Delay and Disorders in Children
Note: The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient…
School bullying and peer relationships in children with… : PAIN
in anxiety in children and adolescents with chronic pain has not yet been examined. This study sought to expand our understanding of the associations between…
Unleashing Potential | Dana-Farber Cancer Institute
AI-based cancer diagnostic tools have fit rather seamlessly into clinical practice. They have also hinted at the potential for AI to benefit patients in other…
The Deloitte Health Equity Institute
Learn how the Deloitte Health Equity Institute is translating purpose into action to advance health equity.
OpenAI customer story: Moderna
Moderna and OpenAI partner to accelerate the development of life-saving treatments.
Equity, technology, and costs top of mind for life science’s leaders
Physicians, researchers, CEOs, reporters, and more gathered in downtown Boston Wednesday night to celebrate STAT’s 2024 STATUS List, which features 50
Adherence to the American Society of Clinical Oncology (ASCO) recommendations for integrating palliative care into standard oncology care
This value you provided is not a number. Please try again. This value you provided is not an integer. Please try again. The value entered…
